** Shares of Australia's McPherson's MCP.AX fall 10.9% to
A$0.1425, on track for their biggest drop since August 27, 2025,
if the trend holds
** Health products supplier says it expects FY26 underlying
EBITDA in the range of A$4 million to A$4.5 million ($2.77
million to $3.11 million), lower than A$7.3 million posted in
the prior corresponding period
** Sees FY26 revenue from continuing operations of A$115.0
million to A$120.0 million vs A$139.0 million in FY25
** MCP down 40.6% YTD
($1 = 1.4455 Australian dollars)
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))